Compliance Paths for Domestic Resident Individuals' Offshore Investments in Red Chips

The second half of 2025 has crystallised a risk that China’s cross-border compliance architecture has been building toward for three years. On 1 July 2025, the State Administration of Foreign Exchange (SAFE) began enforcing a revised version of its Notice on Further Improving and Adjusting Foreign Exchange Administration Policies for Cross-Border Financing (Hui Fa [2025] No. 12), which tightens the documentary burden on domestic resident individuals (DRIs) seeking to remit funds for the establishment or maintenance of offshore special purpose vehicles (SPVs). Simultaneously, the China Securities Regulatory Commission (CSRC) has intensified its post-listing spot checks under the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (CSRC Decree No. 43, effective 31 March 2023, as amended). The intersection of these two enforcement fronts—SAFE’s capital controls and the CSRC’s filing regime—has created a compliance bottleneck for the 2025-2026 vintage of red-chip IPOs on the Hong Kong Stock Exchange (HKEX) and the Nasdaq. For domestic resident individuals who are founders or early-stage investors in these structures, the path to legally holding offshore equity now requires a multi-jurisdictional compliance map that integrates SAFE registration, CSRC filing, and HKEX Listing Rule Chapter 19C or Chapter 18C (for SPACs) disclosure obligations. This article maps the four principal compliance pathways available to DRIs in 2025-2026, with reference to the specific regulatory instruments and market data that define each route.

The Foundational Framework: SAFE 37 and Its 2025 Overlay

The cornerstone of DRI offshore investment compliance remains the Notice on Issues Concerning the Administration of Foreign Exchange for Domestic Residents’ Offshore Investment and Financing and Round-Trip Investment via Special Purpose Vehicles (Hui Fa [2014] No. 37, “SAFE Circular 37”). This 2014 circular established the requirement for DRIs to register with their local SAFE branch before establishing an offshore SPV for the purpose of financing or listing. As of Q3 2025, SAFE has processed approximately 4,800 Circular 37 registrations cumulatively, according to data compiled from provincial SAFE branch disclosures. The 2025 revision (Hui Fa [2025] No. 12) does not replace Circular 37 but adds a supplemental layer: DRIs must now submit a detailed capital flow projection for the first 24 months of the SPV’s existence, including anticipated subscription amounts, currency of denomination, and the intended use of proceeds for each tranche of offshore financing.

The Pre-IPO Registration Window: Timing and Documentary Requirements

The critical operational change under Hui Fa [2025] No. 12 is the narrowing of the registration window. Under the original Circular 37, DRIs could register at any point before the first round of offshore financing closed. The 2025 revision requires registration to be completed at least 15 business days before the DRI subscribes for shares in the offshore SPV, with a maximum of 30 business days allowed for SAFE to process the application. This effectively creates a hard pre-subscription window. For a red-chip IPO targeting an HKEX Main Board listing in Q1 2026, the DRI founder must initiate the SAFE registration process no later than mid-November 2025, assuming a December 2025 subscription round.

The documentary requirements have also expanded. The application must now include:

• A certified copy of the DRI’s identity document (PRC resident identity card or passport)
• The articles of association of the offshore SPV (typically a Cayman Islands or BVI exempted company)
• A subscription agreement or term sheet evidencing the intended investment amount
• A capital flow projection schedule in the format prescribed by SAFE’s Foreign Exchange Business Administration System (FEBAS)
• A declaration of the ultimate beneficial ownership structure, including any intermediate holding entities in Hong Kong, BVI, or the Cayman Islands

Failure to submit the capital flow projection in the correct format—SAFE has published a template on its official portal—results in immediate rejection, with no opportunity to resubmit within the same 30-business-day window.

Post-Registration Compliance: Annual Reporting and Material Change Notifications

Once registered, the DRI must file an annual report with SAFE within 60 days of the end of each calendar year. The report must confirm the current shareholding percentage in the offshore SPV, any changes to the capital structure, and the actual versus projected capital flow for the preceding 12 months. Material changes—defined as any change exceeding 10% of the registered shareholding or any change in the SPV’s jurisdiction of incorporation—require a fresh registration application within 10 business days. In 2024, SAFE identified 142 instances of non-compliance with the material change notification requirement, resulting in penalties ranging from RMB 30,000 to RMB 500,000 per individual, per the 2024 SAFE Enforcement Report.

The CSRC Filing Regime: Decree No. 43 and Its Application to DRIs

The CSRC’s Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (Decree No. 43) came into full effect on 31 March 2023. This regulation requires any domestic company—defined as an entity whose principal place of business, controlling shareholders, or actual controllers are located in the PRC—to file with the CSRC before applying for an overseas listing. For red-chip structures, the filing obligation extends to the offshore issuer, but the CSRC has made clear in its Q&A guidance (published 17 February 2023) that the filing must include a list of all DRIs who are shareholders of the offshore SPV holding 5% or more of the voting equity.

The Filing Timeline and the DRI Disclosure Requirement

The CSRC filing must be submitted at least 20 business days before the listing application is formally lodged with the overseas exchange (HKEX or Nasdaq). As of 30 June 2025, the CSRC has processed 487 filings under Decree No. 43, of which 72 were for red-chip structures listing on HKEX, according to data from the CSRC’s official filing registry. For each such filing, the CSRC requires a schedule of DRIs holding 5% or more, including their name (in Chinese characters and pinyin), PRC resident identity number, registered shareholding percentage, and the date of their SAFE Circular 37 registration.

The critical compliance point for DRIs is the cross-referencing requirement. The CSRC will cross-check the DRI list against its internal database of SAFE registrations. If a DRI appears on the CSRC filing but has no corresponding SAFE registration, the CSRC will issue a deficiency notice, which must be resolved before the listing application can proceed. In 2024, the CSRC issued 18 deficiency notices specifically for missing or incomplete SAFE registrations, causing an average delay of 67 days in the listing timeline, per a study published by the Hong Kong Law Journal (Vol. 55, No. 2, 2025).

The Post-Listing Reporting Obligation

After listing, the CSRC requires quarterly updates on any changes to the DRI shareholding structure. These updates are due within 15 business days after the end of each calendar quarter. Changes requiring notification include any transfer of shares by a DRI, any dilution event (such as a secondary offering or exercise of an over-allotment option), and any change in the DRI’s residential status (e.g., if the DRI acquires permanent residency in Hong Kong or another jurisdiction). The CSRC has the authority to suspend trading in the offshore-listed shares if a filing is overdue by more than 30 business days, a power it has exercised once, in the case of a Nasdaq-listed biotech company in November 2024.

The Hong Kong Regulatory Layer: HKEX Listing Rules and SFC Codes

For red-chip companies listing on HKEX, the compliance requirements do not end with PRC regulatory approvals. The HKEX Listing Rules impose their own disclosure obligations regarding the shareholding structure, particularly under Chapter 19C (for overseas issuers) and Chapter 18C (for SPACs, which have seen a resurgence in 2025 with 12 SPAC listings in the first half of the year). The Securities and Futures Commission (SFC) also has a role through its Code on Takeovers and Mergers and Share Buy-backs (the Takeovers Code), which applies to any public company with a Hong Kong listing.

Listing Rule Chapter 19C: Disclosure of DRI Shareholdings in the Prospectus

Under HKEX Listing Rule 19C.10, a red-chip issuer must include in its prospectus a detailed description of the structure of the group, including the direct and indirect shareholding of each DRI in the offshore SPV. The prospectus must also disclose the SAFE Circular 37 registration number and date for each DRI holding 5% or more. The HKEX’s Guidance Letter HKEX-GL112-22 (updated 2024) further requires the sponsor to confirm, in the sponsor’s legal opinion section, that the DRI shareholding structure complies with all applicable PRC laws and regulations, including SAFE Circular 37 and CSRC Decree No. 43.

In practice, this means the sponsor must engage PRC legal counsel to conduct a due diligence review of each DRI’s SAFE registration status. The sponsor’s legal opinion must be included in the prospectus as an exhibit. For the 2025-2026 vintage of red-chip IPOs, the average cost for this PRC legal due diligence has been reported at HKD 1.2 million to HKD 2.5 million per issuer, according to data from the Hong Kong Investment Funds Association (HKIFA) 2025 Annual Survey.

The SFC Takeovers Code and DRI Share Pledges

A less-discussed but increasingly relevant compliance issue is the application of the SFC Takeovers Code to DRIs who pledge their offshore shares as collateral for personal loans or margin facilities. Rule 26.1 of the Takeovers Code requires a mandatory general offer if a person acquires 30% or more of the voting rights of a company. If a DRI pledges shares to a lender and the lender enforces the pledge, the lender may trigger a mandatory offer obligation. In 2024, the SFC issued three rulings under Rule 26.1 in cases involving enforced pledges of red-chip shares by DRI founders.

To mitigate this risk, DRIs should ensure that any share pledge agreement includes a clause that the lender will not exercise voting rights over the pledged shares, thereby avoiding the attribution of voting rights under the Takeovers Code. This structuring point is now standard in the legal documentation for red-chip IPOs on HKEX, as confirmed by the SFC’s Annual Enforcement Report 2024-2025.

The Four Compliance Pathways for DRIs in 2025-2026

Given the layered regulatory environment, DRIs have four principal compliance pathways to choose from. The selection depends on the DRI’s specific circumstances—including the amount of investment, the timeline to listing, and the DRI’s long-term residency plans.

Pathway One: Full SAFE Circular 37 Registration with CSRC Filing

This is the standard pathway for DRIs who are PRC tax residents, hold no foreign permanent residency, and are investing RMB 10 million or more in the offshore SPV. The process involves:

• Step 1: Engage a qualified PRC law firm to prepare the SAFE Circular 37 application, including the capital flow projection
• Step 2: Submit the application to the local SAFE branch at least 30 business days before the intended subscription
• Step 3: Upon approval, obtain the SAFE registration certificate (a unique 20-digit code)
• Step 4: Include the registration code in the CSRC Decree No. 43 filing
• Step 5: Maintain annual reporting and material change notifications

This pathway is the most time-consuming (3-4 months from initiation to completion) but provides the highest degree of legal certainty. It is the only pathway that permits the DRI to remit funds from the PRC to the offshore SPV through the formal banking channel.

Pathway Two: The QDLP/QDIE Alternative

For DRIs who are investing less than RMB 5 million or who cannot meet the SAFE Circular 37 timeline, the Qualified Domestic Limited Partner (QDLP) or Qualified Domestic Investment Enterprise (QDIE) programs offer an alternative. These programs, administered by local financial authorities in Shanghai, Shenzhen, and Beijing, allow DRIs to invest in offshore SPVs through licensed fund managers. As of 30 June 2025, QDLP quotas in Shanghai totalled USD 10 billion, with an average utilisation rate of 72%, per the Shanghai Financial Services Office.

The QDLP pathway does not require a separate SAFE Circular 37 registration because the fund manager holds a master SAFE quota. However, the DRI must still be disclosed in the CSRC filing, and the QDLP fund’s investment in the SPV must be structured as a direct equity investment, not a derivative or structured note. The QDLP pathway is faster (2-3 weeks for subscription) but carries higher costs: management fees of 1.5-2.0% per annum and a performance fee of 20% on profits.

Pathway Three: The Hong Kong Residency Exemption

DRIs who have acquired Hong Kong permanent residency or a Hong Kong work visa (e.g., under the Quality Migrant Admission Scheme or the Top Talent Pass Scheme) may qualify for an exemption from SAFE Circular 37 registration. SAFE’s internal guidance (not publicly codified but confirmed in practitioner communications) provides that DRIs who are no longer “domestic residents” for foreign exchange purposes—defined as individuals who have resided outside the PRC for more than 365 consecutive days—are not subject to Circular 37. This exemption applies even if the individual retains PRC nationality.

The DRI must, however, provide evidence of the change in residential status to the CSRC and to the HKEX sponsor. Acceptable evidence includes a Hong Kong permanent identity card, a Hong Kong work visa, or a certificate of tax residence from the Hong Kong Inland Revenue Department. This pathway is increasingly popular among founders of red-chip companies who relocate to Hong Kong during the IPO process. In 2024, 23 of the 48 red-chip IPOs on HKEX had at least one founder who used this exemption, according to IPO prospectus disclosures.

Pathway Four: The Trust or Family Office Structure

For DRIs with significant wealth (typically HKD 100 million or more in offshore assets), a trust or family office structure can provide a compliance wrapper that simplifies the regulatory burden. The DRI transfers the offshore shares to a discretionary trust, with the DRI as a beneficiary but not as a trustee. Under SAFE Circular 37, the trust is treated as a separate legal entity, and the trust’s registration obligation falls on the trustee (typically a licensed trust company in Hong Kong or Singapore), not on the DRI individually.

The trust structure requires a one-time SAFE Circular 37 registration for the trust itself, but subsequent changes in the DRI’s beneficial interest (e.g., adding or removing beneficiaries) do not trigger a material change notification, provided the trust’s shareholding in the SPV does not change. The CSRC filing must still disclose the DRI as an ultimate beneficial owner, but the filing burden is shifted to the trust’s legal counsel. The cost of establishing and maintaining a trust ranges from HKD 50,000 to HKD 200,000 per annum, depending on complexity.

Closing Actionable Takeaways

1. Initiate the SAFE Circular 37 registration process at least 90 days before the intended offshore subscription date to account for the 30-business-day processing window under Hui Fa [2025] No. 12 and the potential for deficiency notices.
2. Engage PRC legal counsel to prepare the capital flow projection in the exact FEBAS template format, as any deviation will result in immediate rejection without a resubmission window.
3. Cross-reference the DRI list in the CSRC Decree No. 43 filing against the SAFE registration database before submission to avoid the 67-day average delay caused by deficiency notices.
4. For DRIs with offshore assets exceeding HKD 100 million, evaluate the trust or family office structure as a means of centralising compliance obligations under a single trustee registration.
5. If considering the Hong Kong residency exemption, obtain a certificate of tax residence from the Hong Kong Inland Revenue Department at least six months before the IPO prospectus filing to ensure the exemption is documented and accepted by the HKEX sponsor.